A Mayo Clinic Comprehensive Cancer Center researcher will share findings from a late-breaking abstract at the 2024 Society of Urologic Oncology Annual Meeting in Dallas, Dec. 4–6.
Dec 5, 2024
0
1
Every so often there is an urgent call for a national prostate cancer screening program to be introduced, usually following the diagnosis of a high-profile person with the disease.
Nov 28, 2024
0
5
A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with ...
Nov 12, 2024
0
33
Patients with advanced bladder cancer that has spread to other parts of the body (metastasized) have responded well in a phase I clinical trial of an investigational drug, TYRA-300. The drug targets changes in the FGFR3 gene ...
Oct 24, 2024
0
1
A study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. The study is published in the October 9, 2024, online issue of Neurology. Types of cancers found ...
Oct 9, 2024
0
0
How bladder cancer originates and progresses has been illuminated as never before in a study led by researchers at Weill Cornell Medicine and the New York Genome Center. The researchers found that antiviral enzymes that mutate ...
Oct 9, 2024
0
25
Researchers are a step closer to revolutionizing how doctors use radiotherapy to treat patients with muscle-invasive bladder cancer.
Oct 7, 2024
0
0
Final results from the SWOG S1011 randomized Phase III clinical trial, published in the New England Journal of Medicine, indicate patients undergoing surgery for localized muscle-invasive bladder cancer derive no significant ...
Oct 2, 2024
0
1
A new study in mice by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) has identified a promising drug combination for the treatment of muscle-invasive bladder cancer. Rosiglitazone plus trametinib worked ...
Sep 25, 2024
0
56
Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients with locally advanced or metastatic bladder cancer. The results, published ...
Sep 19, 2024
0
1
Bladder cancer is any of several types of malignancy arising from the epithelial lining (i.e. "the urothelium") of the urinary bladder. The bladder is rarely involved by non-epithelial cancers (such as lymphoma or sarcoma) but these are not properly included in the colloquial term "bladder cancer." It is a disease in which abnormal cells multiply without control in the bladder. The bladder is a hollow, muscular organ that stores urine; it is located in the pelvis. The most common type of bladder cancer recapitulates the normal histology of the urothelium and is known as transitional cell carcinoma.
This text uses material from Wikipedia licensed under CC BY-SA
